Citadel Advisors
MGNX icon

Citadel Advisors’s MacroGenics MGNX Stock Holding History

Citadel Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Sell
57,800
-28,500
-33% -$60.8K ﹤0.01% 11591
2025
Q4 		$139K Buy
86,300
+56,500
+190% +$88.8K ﹤0.01% 11387
2025
Q3 		$50.1K Sell
29,800
-5,100
-15% -$8.26K ﹤0.01% 12210
2025
Q2 		$42.2K Buy
34,900
+1,700
+5% +$2.47K ﹤0.01% 11852
2025
Q1 		$42.2K Buy
33,200
+4,900
+17% +$12.8K ﹤0.01% 12487
2024
Q4 		$92K Sell
28,300
-38,100
-57% -$137K ﹤0.01% 11604
2024
Q3 		$218K Buy
66,400
+9,500
+17% +$37K ﹤0.01% 9969
2024
Q2 		$242K Buy
56,900
+300
+0.5% +$2.92K ﹤0.01% 9554
2024
Q1 		$833K Buy
56,600
+52,200
+1,186% +$789K ﹤0.01% 7320
2023
Q4 		$42.3K Buy
4,400
+4,100
+1,367% +$28.3K ﹤0.01% 11960
2023
Q3 		$1.4K Sell
300
-11,200
-97% -$55.8K ﹤0.01% 13874
2023
Q2 		$61.5K Sell
11,500
-17,300
-60% -$107K ﹤0.01% 11558
2023
Q1 		$206K Buy
28,800
+23,400
+433% +$141K ﹤0.01% 10134
2022
Q4 		$36.2K Buy
+5,400
New +$29.6K ﹤0.01% 12527
2021
Q4 		– Sell
-34,100
Closed -$714K – 14383
2021
Q3 		$714K Buy
34,100
+10,400
+44% +$251K ﹤0.01% 9022
2021
Q2 		$637K Sell
23,700
-7,600
-24% -$223K ﹤0.01% 9473
2021
Q1 		$997K Buy
31,300
+2,000
+7% +$48.6K ﹤0.01% 8116
2020
Q4 		$670K Buy
29,300
+2,100
+8% +$48.3K ﹤0.01% 7579
2020
Q3 		$685K Buy
27,200
+12,100
+80% +$330K ﹤0.01% 6732
2020
Q2 		$422K Buy
+15,100
New +$262K ﹤0.01% 7354
2019
Q4 		– Sell
-170,500
Closed -$2.18M – 9492
2019
Q3 		$2.18M Buy
+170,500
New +$2.46M ﹤0.01% 4351
2019
Q2 		– Sell
-14,300
Closed -$257K – 9589
2019
Q1 		$257K Buy
+14,300
New +$247K ﹤0.01% 7844

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Citadel Advisors's MGNX Position: Q1 2026 in Review

Citadel Advisors reduced its MacroGenics (MGNX) stake by 24% in Q1 2026, selling an estimated $539K and leaving 782,618 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #5832.

Citadel Advisors first reported a position in MGNX in Q1 2014 and has held it in 44 quarters since. The position peaked at $73.9M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Citadel Advisors held 782,618 shares of MacroGenics worth $2.26M as of Q1 2026.
  • Citadel Advisors sold 252,535 MacroGenics shares in Q1 2026, an estimated $539K.
  • MacroGenics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5832 holding.
  • Citadel Advisors first reported a position in MacroGenics in Q1 2014 and has held it in 44 quarters since.
  • Citadel Advisors's MacroGenics position peaked at $73.9M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.